Rossi Jéssica de Oliveira, Araujo Emilie Maria Cabral, Camargo Maria Eduarda Côrtes, Ferreira Junior Rui Seabra, Barraviera Benedito, Miglino Maria Angélica, Nogueira Dayane Maria Braz, Reis Carlos Henrique Bertoni, Gil Guilherme Eugênio, Vinholo Thaís Rissato, Soares Thiago Pereira, Buchaim Rogerio Leone, Buchaim Daniela Vieira
Occupational Medicine, Marilia School of Medicine (FAMEMA), Marilia 17519-030, Brazil.
Department of Biological Sciences, Bauru School of Dentistry (FOB/USP), University of São Paulo, Bauru 17012-901, Brazil.
Materials (Basel). 2024 Sep 3;17(17):4351. doi: 10.3390/ma17174351.
Biomaterials and biopharmaceuticals for correcting large bone defects are a potential area of translational science. A new bioproduct, purified from snake venom and fibrinogen from buffalo blood, aroused interest in the repair of venous ulcers. Expanding potential uses, it has also been used to form biocomplexes in combination with bone grafts, associated with physical therapies or used alone. The aim of this preclinical study was to evaluate low-level laser photobiomodulation (PBM) in critical defects in the calvaria of rats filled with nanohydroxyapatite (NH) associated with the heterologous fibrin biopolymer (HFB). Sixty animals were used, divided into six groups ( = 10 each): G1 (NH); G2 (HFB); G3 (NH + HFB); G4 (NH + PBM); G5 (HFB + PBM); G6 (NH + HFB + PBM). PBM simultaneously used red (R) and infrared (IR) light emission, applied intraoperatively and twice a week, until the end of the experiment at 42 days. Microtomography, bone formation can be seen initially at the margins of the defect, more evident in G5. Microscopically, bone formation demonstrated immature and disorganized trabeculation at 14 days, with remnants of grafting materials. At 42 days, the percentage of new bone formed was higher in all groups, especially in G5 (HFB, 45.4 ± 3.82), with collagen fibers at a higher degree of maturation and yellowish-green color in the birefringence analysis with Picrosirius-red. Therefore, it is concluded that the HFB + PBM combination showed greater effectiveness in the repair process and presents potential for future clinical studies.
用于修复大骨缺损的生物材料和生物制药是转化科学的一个潜在领域。一种从蛇毒和水牛皮血纤维蛋白原中纯化出来的新型生物产品,引起了人们对静脉溃疡修复的兴趣。随着潜在用途的不断拓展,它还被用于与骨移植结合形成生物复合物,联合物理治疗或单独使用。这项临床前研究的目的是评估低强度激光光生物调节(PBM)对大鼠颅骨关键缺损的作用,这些缺损填充有与异源纤维蛋白生物聚合物(HFB)相关的纳米羟基磷灰石(NH)。使用了60只动物,分为六组(每组 = 10只):G1(NH);G2(HFB);G3(NH + HFB);G4(NH + PBM);G5(HFB + PBM);G6(NH + HFB + PBM)。PBM同时使用红色(R)和红外(IR)光发射,术中应用,每周两次,直至42天实验结束。显微断层扫描显示,骨形成最初可见于缺损边缘,在G5组更为明显。显微镜下,14天时骨形成显示小梁结构不成熟且紊乱,伴有移植材料残留。42天时,所有组新形成骨的百分比均较高,尤其是G5组(HFB,45.4 ± 3.82),在使用天狼星红进行双折射分析时,胶原纤维成熟度更高,呈黄绿色。因此,得出结论,HFB + PBM组合在修复过程中显示出更大的有效性,并具有未来临床研究的潜力。